AI-Stroke Completes $4.6M Seed Funding Round
AI-Stroke, a rising MedTech startup from France, has successfully raised $4.6 million in a seed funding round to further develop its innovative AI-powered stroke triaging system. The funding was primarily led by Heka, a division of Newfund VC that focuses on BrainTech, along with support from notable angel investors and the investment arm of Bpifrance.
The Vision Behind AI-Stroke
Founded in 2022, AI-Stroke was established by a group of engineers, physicians, and experienced investors. Their goal is to revolutionize stroke assessments by enabling quick evaluations using commonplace devices like smartphones and tablets. In practice, paramedics or triage nurses will capture a brief 30-second video of the patient. The AI then processes this video to evaluate facial symmetry, arm movement, and speech clarity—all crucial indicators of a potential stroke—within mere seconds before any CT imaging is conducted.
Unique Approach Using Vast Data
The technology behind AI-Stroke leverages the largest collection of clinically annotated stroke videos, encompassing 20,000 videos and nearly 6 million images. This extensive dataset allows the AI system to identify true stroke cases twice as effectively as traditional methods during studies conducted with 2,000 EMS personnel. The system seamlessly integrates with existing pre-hospital protocols like the FAST and CPSS, ensuring a smooth adoption process.
Expert Guidance with a Stellar Advisory Board
In its pursuit of enhancing stroke triaging, AI-Stroke has recently appointed four esteemed stroke specialists to its Medical Advisory Board:
- Dr. Gregory W. Albers, Director of the Stanford Stroke Center and Co-founder of RapidAI
- Prof. Gary Ford from Oxford University Hospitals and NICE (UK), co-creator of the FAST test
- Dr. Sean Savitz, Director of Institute for Stroke and Cerebrovascular Disease at UTHealth Houston
- Dr. Pankajavalli Ramakrishnan, a neurointervention specialist from Westchester Medical Center Health Network
Future Directions and System Impact
Cédric Javault, the CEO of AI-Stroke, expressed enthusiasm about the seed round, stating, "This round strengthens our mission to equip every ambulance and emergency department with AI-driven neurological support. By shortening the time to treatment, we can save more lives and improve outcomes worldwide."
Additionally, Simon Jiafeng Li, the Chief Business Officer, remarked, "With new funds and this distinguished advisory team on board, we're ready to make AI-powered stroke detection a new standard of care." Constant Beroulle, an investor with Newfund Heka, added that AI-Stroke presents an innovative solution to a significant, yet often overlooked, medical challenge—the pre-hospital stroke triaging process.
About AI-Stroke
AI-Stroke SAS is pioneering the development of the world’s first AI neurologist specifically designed for pre-hospital stroke triaging. The company is dedicated to enhancing treatment outcomes for stroke patients through the integration of advanced technology into emergency medical practices.
Contact Information
For more information, please reach out to Simon Jiafeng Li, Chief Business Officer, via email at [Email Protected]. Learn more about AI-Stroke by visiting their official website.
Frequently Asked Questions
What is AI-Stroke?
AI-Stroke is a MedTech startup that specializes in developing AI technology to enhance pre-hospital assessments for stroke patients.
How much funding did AI-Stroke raise?
AI-Stroke raised a total of $4.6 million in its recent seed funding round.
What is the purpose of the funding?
The funds will support AI-Stroke's FDA regulatory pathway and clinical studies at various stroke centers in the U.S.
Who are the experts on the Medical Advisory Board?
The advisory board includes renowned stroke specialists from prestigious institutions, enhancing AI-Stroke's strategic direction.
How does AI-Stroke's technology work?
AI-Stroke's solution analyzes videos recorded by paramedics to identify signs of stroke by assessing facial symmetry, speech, and arm movement.